First Eagle Investment Management
BBNX icon

First Eagle Investment Management’s Beta Bionics BBNX Stock Holding History

First Eagle Investment Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-242,000
Closed -$2.42M – 461
2026
Q1 		$2.42M Sell
242,000
-11,702
-5% -$173K ﹤0.01% 313
2025
Q4 		$7.73M Buy
253,702
+20,500
+9% +$547K 0.01% 203
2025
Q3 		$4.63M Buy
+233,202
New +$4.1M 0.01% 262

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

First Eagle Investment Management's BBNX Position: Q2 2026 in Review

First Eagle Investment Management sold out of Beta Bionics (BBNX) in Q2 2026, closing a stake of 242,000 shares — an estimated $2.42M sold.

First Eagle Investment Management first reported a position in BBNX in Q3 2025 and held it in 3 quarters. The position peaked at $7.73M in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • First Eagle Investment Management reported no remaining Beta Bionics position as of Q2 2026 after selling out during the quarter.
  • First Eagle Investment Management sold 242,000 Beta Bionics shares in Q2 2026, an estimated $2.42M.
  • First Eagle Investment Management first reported a position in Beta Bionics in Q3 2025 and held it in 3 quarters.
  • First Eagle Investment Management's Beta Bionics position peaked at $7.73M in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on First Eagle Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.